Clinical Outcome of Pedicle-Sparing Transfacet Diskectomy and Fusion with Segmental Instrumentation for Thoracic Disc Herniation
Journal of Neurological Surgery Part A: Central European Neurosurgery · 01.05.2024 · 85 (03) · 240-245
DOI: 10.1055/a-2005-0620 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurological Surgery Part A: Central European Neurosurgery, erschienen am 01.05.2024. Verfasst von Keyvan Eghbal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Intervertebral Disc Displacement, Spinal Fusion, Benzophenones, Polymers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Background
Thoracic disk herniations (TDHs) are relatively rare compared with their cervical and lumbar counterparts. Posterior approaches allow for a simpler and less invasive surgery than anterior and lateral approaches. A pedicle-sparing transfacet approach was initially described in 1995, and modified in 2010. A few clinical series have reported the outcome of this procedure in patients with TDH. This study aimed to evaluate the outcomes and complications of pedicle-sparing transfacet diskectomy with interbody fusion and segmental instrumentation in patients with TDH.
Methods
Twenty-one consecutive patients with symptomatic TDH referred to our tertiary care center were included in this retrospective study. All patients underwent a pedicle-sparing transfacet diskectomy with polyetheretherketone (PEEK) cage interbody fusion and short segmental instrumentation. Distribution of TDH, operative duration, blood loss, Visual Analog Scale (VAS) pain scores, Nurick grades, modified Japanese Orthopaedic Association (mJOA) scores, and fusion rate were assessed.
Results
All patients had single-level herniations. The most common location was T12–L1 (38.1%), followed by T11–T12 (33.3%). All patients were successfully operated on with no cerebrospinal fluid (CSF) leaks or wrong-level surgery. The VAS scores significantly diminished from 4.9 (preoperatively) to 2 (18 months after surgery). The average mJOA score increased from 4.6 to 8.5, and the average Nurick grade decreased from 3.1 to 1.6. All patients reported significant improvement in quality of life relative to their preoperative status.
Conclusion
A modified pedicle-sparing transfacet diskectomy combined with PEEK cage interbody fusion and segmental instrumentation offers a safe and less invasive approach for the treatment of TDHs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Surgery, Rafsanjan University of Medical Sciences, Kerman, Iran.
- Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Keyvan Eghbal, Saber Zafarshamspour
Zitieren
APA
Eghbal, K., Zafarshamspour, S., Sookhaklari, M., Saffarian, A., & Taheri, R. (2024). Clinical Outcome of Pedicle-Sparing Transfacet Diskectomy and Fusion with Segmental Instrumentation for Thoracic Disc Herniation. Journal of Neurological Surgery Part A: Central European Neurosurgery, 85(03), 240-245. https://doi.org/10.1055/a-2005-0620
Vancouver
Eghbal K, Zafarshamspour S, Sookhaklari M, Saffarian A, Taheri R. Clinical Outcome of Pedicle-Sparing Transfacet Diskectomy and Fusion with Segmental Instrumentation for Thoracic Disc Herniation. Journal of Neurological Surgery Part A: Central European Neurosurgery. 2024;85(03):240-245. doi:10.1055/a-2005-0620
BibTeX
@article{Eghbal2024,
author = {Eghbal, Keyvan and Zafarshamspour, Saber and Sookhaklari, Mohammadamin and Saffarian, Arash and Taheri, Reza},
title = {Clinical Outcome of Pedicle-Sparing Transfacet Diskectomy and Fusion with Segmental Instrumentation for Thoracic Disc Herniation},
journal = {Journal of Neurological Surgery Part A: Central European Neurosurgery},
year = {2024},
volume = {85},
number = {03},
pages = {240--245},
doi = {10.1055/a-2005-0620}
}
EUVIMED